Consistent with a recent encounter with tumor antigens, DP CD8+ T cells expressed higher frequencies of the proliferative marker Ki67, expressed more coinhibitory markers (PD-1 and TIM-3), and presented a less cytotoxic phenotype with lower basal levels of granzyme B and perforin than DN CD8+ T cells. The gene discussed is GZMB; the disease is neoplasm.